Israel Englander Celldex Therapeutics, Inc. Transaction History

Millennium Management LLC

$213 Billion
Q3 2025

A detailed history of Israel Englander (Millennium Management LLC) transactions in Celldex Therapeutics, Inc. stock. As of the latest transaction made, Millennium Management LLC holds 975,195 shares of CLDX stock, worth $24.9 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

975,195

Previous 477,227 104.35%

Holding current value

$24.9 Million

Previous $9.71 Million 159.79%

% of portfolio

0.01%

Previous 0.01%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Nov 14, 2025	BUY	$20.01 - $26.19 $9.96 Million - $13 Million	497,968 Added 104.35%	975,195 $25.2 Million
Q2 2025 Aug 14, 2025	BUY	$15.13 - $21.65 $1.17 Million - $1.67 Million	77,295 Added 19.33%	477,227 $9.71 Million
Q1 2025 May 15, 2025	BUY	$18.15 - $27.6 $5.56 Million - $8.45 Million	306,330 Added 327.27%	399,932 $7.26 Million
Q4 2024 Feb 14, 2025	SELL	$23.31 - $32.4 $338,018 - $469,832	-14,501 Reduced 13.41%	93,602 $2.37 Million
Q3 2024 Nov 14, 2024	BUY	$32.06 - $44.56 $2.06 Million - $2.87 Million	64,353 Added 147.09%	108,103 $3.67 Million

Q2 2024 Aug 14, 2024	SELL	$32.76 - $42.56 $5.39 Million - $7 Million	-164,501 Reduced 78.99%	43,750 $1.62 Million
Q1 2024 May 15, 2024	BUY	$35.22 - $51.88 $6.95 Million - $10.2 Million	197,254 Added 1793.71%	208,251 $8.74 Million
Q4 2023 Feb 14, 2024	SELL	$22.61 - $40.65 $220,289 - $396,052	-9,743 Reduced 46.98%	10,997 $436,000
Q2 2023 Aug 14, 2023	BUY	$30.29 - $38.28 $628,214 - $793,927	20,740 New	20,740 $703,000
Q4 2022 Feb 14, 2023	BUY	$27.78 - $45.38 $954,270 - $1.56 Million	34,351 New	34,351 $1.53 Million
Q2 2022 Aug 15, 2022	BUY	$20.5 - $37.33 $730,661 - $1.33 Million	35,642 Added 33.09%	143,343 $3.87 Million
Q1 2022 May 16, 2022	BUY	$27.64 - $39.32 $1.88 Million - $2.67 Million	68,030 Added 171.49%	107,701 $3.67 Million
Q4 2021 Feb 14, 2022	BUY	$35.68 - $56.27 $1.42 Million - $2.23 Million	39,671 New	39,671 $1.53 Million
Q2 2021 Aug 16, 2021	SELL	$20.71 - $35.37 $10.5 Million - $17.9 Million	-505,163 Closed	0 $0
Q1 2021 May 17, 2021	BUY	$16.19 - $29.91 $4.84 Million - $8.95 Million	299,241 Added 145.32%	505,163 $10.4 Million
Q4 2020 Feb 16, 2021	BUY	$14.99 - $22.75 $3.09 Million - $4.68 Million	205,922 New	205,922 $3.61 Million
Q3 2020 Nov 16, 2020	SELL	$9.65 - $15.19 $4.15 Million - $6.54 Million	-430,564 Closed	0 $0
Q2 2020 Aug 14, 2020	BUY	$1.61 - $13.41 $693,208 - $5.77 Million	430,564 New	430,564 $5.6 Million

Others Institutions Holding CLDX

# of Institutions

206

Shares Held

66.8M

Call Options Held

222K

Put Options Held

234K

View Full List

About Celldex Therapeutics, Inc.

Ticker CLDX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 46,772,400
Market Cap $1.2B
Description
Celldex Therapeutics, Inc., a biopharmaceutical company, engages in developing therapeutic monoclonal and bispecific antibodies for the treatment of various diseases. Its drug candidates include antibody-based therapeutics to treat patients with inflammatory diseases and various forms of cancer. The company's clinical development programs CDX-01...

More about CLDX

Track Israel Englander's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Millennium Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Millennium Management LLC and Israel Englander with notifications on news.

Account